Skip to main content
logo
LTR Pharma Limited (ASX:LTP)
Australia flag Australia · Delayed Price · Currency is AUD
0.4650
+0.0150 (3.33%)
At close: Jul 31, 2026

LTR Pharma Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Revenue
1.131.510.05-0.01-
Revenue Growth
-24.99%2978.25%----
Gross Profit
-3.4-1.28-3.46-0.01-
Operating Income
-9.78-6.11-6.94-1.44-1.02-0.03
Net Income
-8.95-5.59-6.95-1.45-1.03-0.04
Earnings Per Share
-0.05-0.03-0.05-0.01--
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Investments
25.7831.813.11.731.910.15
Total Debt
-----0.36
Net Cash (Debt)
25.7831.813.11.731.91-0.21
Net Cash Growth
-18.95%925.31%79.46%-9.56%--
Net Cash Per Share
0.140.190.020.01--

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Operating Cash Flow
-6.96-4.44-5.09-1.54-0.57-0.03
Capital Expenditures
-0-0.01-0-0--
Free Cash Flow
-6.96-4.45-5.09-1.54-0.57-0.03
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Gross Margin
--84.75%--100.00%-
Operating Margin
-864.79%-404.86%-14162.27%--11195.03%-
Pretax Margin
-791.01%-370.83%-14192.25%--11314.40%-
Profit Margin
-791.01%-370.83%-14192.25%--11314.40%-
FCF Margin
-615.44%-294.96%-10396.58%--6258.86%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
74.7134.792219.25---